TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Octapharma AS
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
145,659
|
453,550
|
449,090 |
| Financial expenses |
1
|
4
|
0 |
| Earnings before taxes |
6,061
|
14,748
|
16,192 |
| Total assets |
39,256
|
136,495
|
150,243 |
| Current assets |
39,047
|
136,405
|
150,159 |
| Current liabilities |
11,343
|
53,520
|
80,918 |
| Equity capital |
27,913
|
82,975
|
69,325 |
| - share capital |
148
|
159
|
154 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.1%
|
60.8%
|
46.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.2%
|
3.3%
|
3.6% |
| Return on assets (ROA) |
15.4%
|
10.8%
|
10.8% |
| Current ratio |
344.2%
|
254.9%
|
185.6% |
| Return on equity (ROE) |
21.7%
|
17.8%
|
23.4% |
| Change turnover |
-277,841
|
-9,455
|
85,974 |
| Change turnover % |
-66%
|
-2%
|
24% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.